Literature DB >> 12095308

An adenoviral expression system for AAV rep78 using homologous recombination.

Cheryl A Carlson1, Dmitry M Shayakhmetov, André Lieber.   

Abstract

The construction and amplification of adenoviral (Ad) vectors expressing biologically active transgenes that are cytotoxic or inhibit Ad replication can be extremely difficult, if not impossible. In this study, we harnessed the ability of Ad genomes to undergo efficient homologous recombination to reconstitute the adeno-associated virus (AAV) rep78 gene, a cytotoxic gene that strongly inhibits Ad replication, which was divided between two parental, first-generation Ad vectors. A functional open reading frame was generated by recombination only upon co-infection of both parental vectors and after the onset of viral DNA replication. We were able to amplify both parental rep78 vectors to normal titers without any signs of inhibition or toxicity and could use them to generate progeny vectors containing a functional rep78 gene without any Ad genes. Using this vector recombination system in AAV rescue assays demonstrated that no Ad protein was essential for Rep78 mediated rescue of AAV ITR flanked DNA from plasmid or Ad backbones; the amount of rescue product generated was substantially greater in the presence of Ad infection; neither cellular nor viral DNA replication was necessary for rescue to occur; and progeny vector genomes were efficiently co-replicated along with conventional, first-generation Ad vectors.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12095308     DOI: 10.1006/mthe.2002.0634

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


  8 in total

1.  Genome size and structure determine efficiency of postinternalization steps and gene transfer of capsid-modified adenovirus vectors in a cell-type-specific manner.

Authors:  Dmitry M Shayakhmetov; Zong-Yi Li; Anuj Gaggar; Helen Gharwan; Vladimir Ternovoi; Volker Sandig; André Lieber
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

2.  Tightly regulated gene expression in human hematopoietic stem cells after transduction with helper-dependent Ad5/35 vectors.

Authors:  Hongje Wang; Hua Cao; Martin Wohlfahrt; Hans-Peter Kiem; André Lieber
Journal:  Exp Hematol       Date:  2008-04-18       Impact factor: 3.084

3.  Development and assessment of human adenovirus type 11 as a gene transfer vector.

Authors:  Daniel Stone; Shaoheng Ni; Zong-Yi Li; Anuj Gaggar; Nelson DiPaolo; Qinghua Feng; Volker Sandig; André Lieber
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

4.  Differential contribution of adeno-associated virus type 2 Rep protein expression and nucleic acid elements to inhibition of adenoviral replication in cis and in trans.

Authors:  Stefan Weger; Eva Hammer; Regine Heilbronn
Journal:  J Virol       Date:  2014-10-01       Impact factor: 5.103

5.  A helper-dependent capsid-modified adenovirus vector expressing adeno-associated virus rep78 mediates site-specific integration of a 27-kilobase transgene cassette.

Authors:  Hongjie Wang; André Lieber
Journal:  J Virol       Date:  2006-09-20       Impact factor: 5.103

6.  Computationally designed adeno-associated virus (AAV) Rep 78 is efficiently maintained within an adenovirus vector.

Authors:  Varsha Sitaraman; Patrick Hearing; Charles B Ward; Dmitri V Gnatenko; Eckard Wimmer; Steffen Mueller; Steven Skiena; Wadie F Bahou
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-15       Impact factor: 11.205

7.  Evaluation of adenovirus vectors containing serotype 35 fibers for vaccination.

Authors:  Nelson DiPaolo; Shaoheng Ni; Anuj Gaggar; Robert Strauss; Sebastian Tuve; Zong Yi Li; Daniel Stone; Dmitry Shayakhmetov; Nancy Kiviat; Papa Touré; Salif Sow; Branka Horvat; André Lieber
Journal:  Mol Ther       Date:  2006-02-07       Impact factor: 11.454

8.  A Regulatory Element Near the 3' End of the Adeno-Associated Virus rep Gene Inhibits Adenovirus Replication in cis by Means of p40 Promoter-Associated Short Transcripts.

Authors:  Stefan Weger; Eva Hammer; Melanie Gonsior; Catrin Stutika; Regine Heilbronn
Journal:  J Virol       Date:  2016-03-28       Impact factor: 5.103

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.